Here's what you need to know about the M&A mania spreading through big pharma.
News & Analysis: TAKEDA PHARM CO LTD S/ADR
Takeda could struggle to finance this megadeal.
On a day benchmarks toggled between gains and losses, Takeda Pharmaceuticals announced it's considering buying Shire, and RH reported big profits.
One simple production choice on the part of cancer drug developers is resulting in some hefty losses for the U.S. healthcare system.
Our contributors think its time to head for the exits on these three biotechs.
Takeda, Eli Lilly, Immunomedics, and Pharmacyclics could loom large in health care headlines this Tuesday morning.
Lower research and development expenses help lower Orexigen's quarterly loss.
These are the 10 countries with the longest life expectancy. See what factors have allowed their citizens to live longer as well as how you might be able to benefit from their longevity.
With Takeda's recent setback, Big Pharma's diabetes cupboard is looking very bare.
An FDA panel gives the green light on the use of vedolizumab to treat patients with ulcerative colitis and Crohn’s disease who failed other treatments.